4-androstene-3,17-diol has been researched along with dehydroepiandrosterone in 2 studies
| Studies (4-androstene-3,17-diol) | Trials (4-androstene-3,17-diol) | Recent Studies (post-2010) (4-androstene-3,17-diol) | Studies (dehydroepiandrosterone) | Trials (dehydroepiandrosterone) | Recent Studies (post-2010) (dehydroepiandrosterone) |
|---|---|---|---|---|---|
| 13 | 1 | 2 | 10,043 | 639 | 1,826 |
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 1 (50.00) | 18.2507 |
| 2000's | 1 (50.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ban, F; Cherkasov, A; Fallahi, M; Hammond, GL; Santos-Filho, O; Thorsteinson, N | 1 |
| Bagchus, WM; Bakker, JM; Kraal, G; Wolvers, DA | 1 |
2 other study(ies) available for 4-androstene-3,17-diol and dehydroepiandrosterone
| Article | Year |
|---|---|
An updated steroid benchmark set and its application in the discovery of novel nanomolar ligands of sex hormone-binding globulin.
Topics: Binding Sites; Binding, Competitive; Computer Simulation; Databases as Topic; Humans; Ligands; Linear Models; Models, Molecular; Predictive Value of Tests; Protein Binding; Quantitative Structure-Activity Relationship; Reproducibility of Results; Sex Hormone-Binding Globulin; Steroids | 2008 |
The steroid hormone dehydroepiandrosterone (DHEA) breaks intranasally induced tolerance, when administered at time of systemic immunization.
Topics: Administration, Intranasal; Androstenediols; Androstenols; Animals; Antibodies; Antibody Formation; Dehydroepiandrosterone; Hypersensitivity, Delayed; Immune Tolerance; Immunization; Male; Mice; Mice, Inbred BALB C; Ovalbumin | 1998 |